Skip to content

Author

Z. Hein

We have 5 of 67 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Mitochondrial Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Primary Drivers Versus Early Amplifiers, and Emerging Mitochondria-Targeted Therapeutic Strategies

Mitochondria are critical for bioenergetics, calcium and redox homeostasis, and apoptosis in neurons. Neurons are especially susceptible to mitochondrial malfunction since they are terminally differentiated and have extraordinary energy requirements. Mechanisms such as defective oxidative phosphorylation, altered fissi...

P. K. Gopalakrishna, Thirupathirao Vishnumukkala, Z. Hein et al. · 0 citations
#gene editing Review Open access Jan 2026

Therapeutic Targeting of Oxidative Stress in Hematopoietic Stem Cells: Current Strategies and Future Directions

The intricate mechanisms by which oxidative stress disrupts HSC self‐renewal, quiescence, and differentiation are discussed, as well as the implications for aging and hematological malignancies.

D. Senthilkumar, S. Venkatachalam, Nallusamy Duraisamy et al. · 0 citations
Open access Sep 2026

Causes of death across the life course in the Association of Southeast Asian Nations (ASEAN): a systematic analysis for the Global Burden of Disease Study 2023

Summary Background The drivers of mortality and their associated risk factors evolve throughout the course of life. Understanding these transitions is essential for effective, equitable, and age-appropriate health interventions. Methods As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 20...

Tai-Shun Li, P. Charalampous, S. C. C. van der Lubbe et al. · 1 citation
Aug 2026

Ficus deltoidea preserves neuronal-glial ultrastructure and attenuates neuroinflammation in an Alzheimer's disease-like rat model.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by β-amyloid (Aβ) plaques, hyperphosphorylated tau tangles, cognitive decline, neuroinflammation, and neuronal-glial dysfunction, yet effective disease-modifying therapies remain unavailable. Increasing evidence suggests that preservatio...

Michael Ayuba, C. M. N. Che Mohd Nassir, Hafizah Abdul Hamid et al. · 0 citations
Open access Aug 2026

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems

The importance of formulation optimization in improving nucleic acid delivery is highlighted and practical insights for enhancing peptide- and lipid-based therapeutic platforms are provided.

D. Daniele, Z. Hein, O. Saher et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.